2nd November 2018

RPS welcomes legalisation of cannabis-derived medicinal products

From 1st November 2018 it is now legal for clinicians on the General Medical Council’s specialist register to prescribe cannabis-derived medicinal products.

Commenting on the transfer of these products from Schedule 1 to Schedule 2 of the Misuse of Drugs Regulations 2001, President of the Royal Pharmaceutical Society Ash Soni said:

“This is a great step forward for patients whose conditions will be improved by better access to cannabis-based medicinal products”.

Read on here:

https://www.rpharms.com/news/details/-RPS-welcomes-legalisation-of-cannabis-derived-medicinal-products

Thousands of patients denied GP follow-up after asthma attack
Thousands of patients denied GP follow-up after asthma attack

12th February 2019

Read
COMMISSIONER WANTS PHARMACISTS INVOLVED
COMMISSIONER WANTS PHARMACISTS INVOLVED

25th January 2019

Read
NHS England update on recommended flu vaccines for 2019/20
NHS England update on recommended flu vaccines for 2019/20

24th January 2019

Read